Advertisement

Hematology and Oncology

Home Hematology and Oncology
The burden of prior authorization has increased over the past five years

Recent Years Saw Increase in Burden of Prior Authorization

Ninety-two percent of physicians report PA-associated delays in patient access to care
Physicians receiving general payments from pharmaceutical companies are more likely to prescribe their drugs

Odds of Prescribing Drugs Up With Doc Receipt of Payments

Doctors who receive general payment for cancer drug more likely to prescribe drug marketed by company
Gemcitabine and cisplatin plus ipilimumab is associated with a 69 percent objective response rate and 61 percent one-year overall survival for patients with metastatic urothelial cancer

Chemo, Immunotherapy Feasible in Metastatic Bladder Cancer

One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab
Men on androgen-deprivation therapy for prostate cancer may significantly benefit from a group exercise and nutrition program

Group Exercise, Nutrition Aids Prostate Cancer Patients on ADT

Improvements seen in mobility, body fat, muscle strength in men on androgen-deprivation therapy
There are considerable differences in the burden of disease at the state level

Considerable Differences in Burden of Disease at State Level

Increasing burden of various diseases depending on state; overall death rates declined
Changes can be implemented to help reduce physician frustration with electronic health records

Suggestions Offered to Reduce Physician Frustration With EHRs

Eight suggestions include providing individualized optimization training to personalize EHR settings
Most people in the United States are unaware of national cancer drug shortages

Most Patients Are Unaware of Drug Cancer Shortages

Majority say they want to know about even minor consequences of cancer drug substitutions
Myocarditis in patients treated with immune checkpoint inhibitors may be more common than previously thought

Myocarditis Rare Side Effect of Immune Checkpoint Inhibitors

Myocarditis with ICIs may be more common than initially thought; responds to higher steroid dosages
Underlying leukemia

Leukemia, and Its Treatment, May Pose Neurocognitive Risks

Cerebrospinal fluid biomarkers may identify those at greater risk for poor neuro-related outcomes
New interns' intense and changing schedules take a toll on sleep

Interns’ Schedule Takes Toll on Sleep, Physical Activity, Mood

Findings based on eight-month evaluation of new interns using Fitbit activity trackers